- About Future
- Digital Future
- Cookies Policy
- Terms & Conditions
- Investor Relations
- Contact Future
Even today, in the wake of the touch-based smartphone revolution that the iPhone initiated, the BlackBerry is still considered the "smartphone of business" for many large companies. As the news about the veteran smartphone developer's woes gets worse and worse, however, many businesses are starting to dump the old standby as their "official" smartphone in favor of options such as the iPhone and Android devices.
As AppleInsider notes (via AllThingsD), the latest defector is pharmaceutical giant Pfizer, which sent out a memo to employees today mentioning BlackBerry's "volatile" state and urging them to switch to either iPhone or Android. Considering that Pfizer has around 90,000 employees, that's a significant blow to the Canadian smartphone maker.
We've covered that volatile situation before. BlackBerry first tried to dig itself out of its hole by selling off assets to companies like Apple, Microsoft, and Lenovo, but all three companies were more interested in BlackBerry's patents than acquiring its hardware or customers. For a while it looked certain that it'd break up or be bought off by Fairfax Capital, but that all changed when CEO Thorsten Heins resigned.
AppleInsider reports that his successor, John Chen (formerly chief executive of Sybase, now believes that he can rebuild BlackBerry, and he claims that it has "significant financial strength for the long haul." Still, it's easy to see why companies like Pfizer might be wary of such claims. After all, BlackBerry recently had to lay off 40 percent of its workforce, prompting companies like Apple and Intel to move in and pick up the newly available talent.
Follow this article's writer, Leif Johnson, on Twitter.